Pharmafile Logo
Pharmafocus logo
Advanced Search

cuts

Showing 15 posts of 48 posts found.

Brandicourt

Sanofi plans R&D jobs cuts in France

February 3, 2016
Manufacturing and Production, Research and Development Sanofi, Teva, cuts, job losses, olivier brandicourt, redundancies

Sanofi chief executive Olivier Brandicourt is reported to be planning hundreds of job cuts across the firm’s base in France, …

News

Counting the true cost of the Cancer Drugs Fund cuts

September 14, 2015
Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology

Leading figures from the pharma industry and cancer charities reacted with dismay to the recent cuts to the Cancer Drugs …

Feature
NHS sign

Companies braced for new round of cancer cuts

September 4, 2015
Medical Communications, Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, cuts

Several treatments that extend the lives of people with cancer are expected to be removed from the Cancer Drugs Fund …

News
GSK image

GSK sees further US job losses following Novartis deal

April 17, 2015
Research and Development, Sales and Marketing GSK, Jobs, Novartis, cuts, merger, pittsburgh, restructuring

Hundreds more jobs are at risk within GlaxoSmithKline as the fallout from the company’s asset-swapping deal with Novartis continues. Staff …

News
Eisai image

Eisai cuts 25% of US staff

April 10, 2015
Medical Communications, Research and Development, Sales and Marketing Daiichi, Eisai, US, cuts, layoffs, reorganisation, staff

Eisai’s US business is offloading around 200 jobs as part of some restructuring to create a more ‘efficient and focussed …

News
Daiichi image

Daiichi Sankyo cuts 16% of US staff

March 27, 2015
Sales and Marketing Benicar, Daiichi Sankyo, FDA, Ranbaxy, Welchol, ambit, colesevelam, cuts, olmesartan

Daiichi Sankyo is laying off 16% of its staff at its US commercial headquarters as the company braces itself for …

News
GSK image

GSK China scandal leads to staff conflict

March 11, 2015
Sales and Marketing China, GSK, GlaxoSmithKline, bribery, chinese, cuts, sacked

Around 135 workers who face being removed from their posts by GlaxoSmithKline due to misconduct centering on bribery scandals in …

News
GSK image

GSK cancels sale of established products

December 5, 2014
Medical Communications, Sales and Marketing FDA, GSK, Paxil, Seroxat, Zantac, bribery, cuts, imitrex

GlaxoSmithKline has decided not to sell off several of its ageing brands in the face of continuing business problems. The …

News
Teva image

Teva to ditch R&D in cancer and women’s health

October 6, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, MS, R&D, Teva, cuts, generics

Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …

News
Boehringer image

Boehringer to slash 600 jobs in native Germany

September 24, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AMNOG, Boehringer, Germany, Novartis, cuts, mergers, staff

Boehringer Ingelheim is to cut around 600 of its staff in Germany as part of a drive to reduce costs …

News
Allergan image

Allergan slashes 1,500 jobs

July 22, 2014
Research and Development, Sales and Marketing Allergan, Botox, Jobs, cuts, valiant

Allergan is to cut 1,500 jobs as part of a restructure which it believes will make pre-tax savings of around …

News
Teva image

Teva to close half its sites

June 17, 2014
Manufacturing and Production, Sales and Marketing Jobs, Teva, cuts, generics, manufacturing

Teva Pharmaceutical Industries is to close around half of its 75 manufacturing sites within the next five years, chief financial …

News
Teva image

Teva considers up to 27 plant closures

May 13, 2014
Manufacturing and Production, Sales and Marketing Copaxone, Nerventra, Teva, cuts, generics

Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …

News
novartis image

Novartis to axe Horsham site

February 27, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure

Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …

News

Novartis may axe 1,000 jobs in Diovan wake

January 23, 2014
Manufacturing and Production, Sales and Marketing Coartem, Diovan, Novartis, cuts

Novartis will shut down a plant in New York State that made heart drug Diovan and malaria treatment Coartem as …

News

Latest content

GSK’s Jemperli approved in EU as treatment for endometrial cancer

December 11, 2023

Daiichi Sankyo shares results for Ezharmia as lymphoma treatment

December 11, 2023

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023